Functional and safety outcomes for the entire cohort and for the subgroup presenting within 4.5 hours of symptom onset
| EV-Only vs IV+EV Entire cohort (n=90) | EV-Only vs IV+EV Onset to presentation ≤4.5 hours (n=64) | |||||
|---|---|---|---|---|---|---|
| EV-Only (n=52) | IV+EV (n=38) | p Value | EV-Only (n=26) | IV+EV (n=38) | p Value | |
| Recanalization | 35 (67) | 31 (81.6) | 0.12 | 21 (81) | 31 (81.6) | 0.93 |
| Favorable outcome | 26 (50) | 22 (58) | 0.45 | 14 (54) | 22 (58) | 0.75 |
| Hemorrhage (PH1/PH2) | 3 (5.8) | 1 (2.6) | 0.46 | 1 (3.8) | 1 (2.6) | 0.78 |
| Mortality | 13 (25) | 4 (10.5) | 0.07 | 5 (19.2) | 4 (10.5) | 0.33 |
| Home discharge | 19 (36.5) | 11 (29) | 0.45 | 11 (42) | 11 (29) | 0.27 |
All values shown are n (%).
EV-Only, endovascular therapy alone group; IV+EV, endovascular therapy following IV rt-PA administration group.